Humankind Benefit Ownership
| HKND Etf | USD 33.83 0.18 0.53% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Humankind |
Humankind Etf Ownership Analysis
Humankind Benefit is is formed as Regulated Investment Company in the United States. ETF is managed and operated by Ultimus Fund Solutions, LLC. The fund has 997 constituents across multiple sectors and instustries. The fund charges 0.11 percent management fee with a total expences of 0.11 percent of total asset. The fund retains 99.85% of assets under management (AUM) in equities. The index is primarily comprised of domestic equity securities and may not be comprised of greater than 5 percent of foreign securities . Humankind is traded on NYSEARCA Exchange in the United States. To learn more about Humankind Benefit call the company at NA.Sector Exposure (%)
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Humankind Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Humankind Benefit , and the less return is expected.
Currency Exposure (%)
Investment Allocations (%)
Top Etf Constituents
| AAPL | Apple Inc | Stock | |
| CTVA | Corteva | Stock | |
| DE | Deere Company | Stock | |
| GOOGL | Alphabet Inc Class A | Stock | |
| HCA | HCA Holdings | Etf | |
| HPQ | HP Inc | Stock | |
| JNJ | Johnson Johnson | Stock | |
| MSFT | Microsoft | Stock | |
| PFE | Pfizer Inc | Stock | |
| VZ | Verizon Communications | Stock |
Humankind Benefit Outstanding Bonds
Humankind Benefit issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Humankind Benefit uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Humankind bonds can be classified according to their maturity, which is the date when Humankind Benefit has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| HUMANA INC 395 Corp BondUS444859BF87 | View | |
| HUMANA INC 48 Corp BondUS444859BG60 | View | |
| HUMANA INC 495 Corp BondUS444859BE13 | View | |
| HUMANA INC 4625 Corp BondUS444859BB73 | View | |
| US444859BM39 Corp BondUS444859BM39 | View | |
| US444859BL55 Corp BondUS444859BL55 | View | |
| US444859BN12 Corp BondUS444859BN12 | View | |
| US444859BK72 Corp BondUS444859BK72 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Humankind Benefit is a strong investment it is important to analyze Humankind Benefit's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Humankind Benefit's future performance. For an informed investment choice regarding Humankind Etf, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humankind Benefit. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
The market value of Humankind Benefit is measured differently than its book value, which is the value of Humankind that is recorded on the company's balance sheet. Investors also form their own opinion of Humankind Benefit's value that differs from its market value or its book value, called intrinsic value, which is Humankind Benefit's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Humankind Benefit's market value can be influenced by many factors that don't directly affect Humankind Benefit's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Humankind Benefit's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humankind Benefit is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humankind Benefit's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.